(Q40132106)

17 September 2017

1 reference

title

Modulation of antitumor immunity--immunobiologic approaches (English)

1 reference

17 September 2017

Modulation of antitumor immunity ? Immunobiologic approaches (English)

1 reference

18 September 2023

1 reference

18 September 2023

author name string

R. J. North

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293113

18 September 2023

E. S. Dye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293113

18 September 2023

C. D. Mills

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293113

18 September 2023

J. P. Chandler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293113

18 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6293113

18 September 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

http://link.springer.com/content/pdf/10.1007/BF00199796.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00199796/fulltext.html

18 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00199796

18 September 2023

1 reference

Seminars in Immunopathology

18 September 2023

published in

1 reference

17 September 2017

5

1 reference

17 September 2017

2

1 reference

17 September 2017

193-220

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00199796

17 September 2017

0 references

1 reference

12 December 2020

Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response

1 reference

12 December 2020

Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue

1 reference

12 December 2020

Antitumor Activity of Corynebacterium Parvum

1 reference

12 December 2020

Partial purification of a serum factor that causes necrosis of tumors

1 reference

12 December 2020

Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon

1 reference

12 December 2020

Immunopotentiation With BCG. IV. Factors Affecting the Magnitude of an Antitumor Response2

1 reference

12 December 2020

Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine

1 reference

12 December 2020

Macrophages in syngeneic animal tumours

1 reference

12 December 2020

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

12 December 2020

Passive Immunotherapy of Cancer in Animals and Man

1 reference

12 December 2020

Macrophage content of tumours in relation to metastatic spread and host immune reaction

1 reference

12 December 2020

Increased toxicity of endotoxin for tumor-bearing mice and mice responding to bacterial pathogens: macrophage activation as a common denominator

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population

1 reference

12 December 2020

Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

1 reference

12 December 2020

Cell-mediated cytotoxicity against syngeneic tumors

1 reference

12 December 2020

Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

1 reference

12 December 2020

Immunological adjuvants in cancer immunotherapy

1 reference

12 December 2020

IMMUNOLOGY OF EXPERIMENTAL TUMORS.

1 reference

12 December 2020

In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors

1 reference

12 December 2020

Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis

1 reference

12 December 2020

T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites

1 reference

12 December 2020

Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity

1 reference

12 December 2020

Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants

1 reference

12 December 2020

Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression

1 reference

12 December 2020

Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts

1 reference

12 December 2020

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity

1 reference

12 December 2020

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice

1 reference

12 December 2020

Immunity to methylcholanthrene-induced sarcomas

1 reference

12 December 2020

Transplantation methods as a tool for detection of tumor-specific antigens

1 reference

12 December 2020

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes

1 reference

12 December 2020

The Choice of Animal Tumors for Experimental Studies of Cancer Therapy

1 reference

12 December 2020

Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis

1 reference

12 December 2020

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin

1 reference

12 December 2020

Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations

1 reference

12 December 2020

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity

1 reference

12 December 2020

A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic exam

1 reference

12 December 2020

Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.

1 reference

12 December 2020

Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice

1 reference

12 December 2020

Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199796

1 reference

17 September 2017

1 reference